Contributions of GlossaryGleb

Contributions by GlossaryGleb, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 10,922 edits includes activity predating the current log.

1. 14:40, 30 Jun 2026 (diff | hist) Talk:Subcutaneous injection 885 +146 /* Usage note on the word subQ */ reply
2. 19:51, 6 Jun 2026 (diff | hist) Satiety signalling 5,593 ±0 add the cleavage site by residue number
3. 13:55, 4 May 2026 (diff | hist) Talk:Glossary of peptide terminology 748 +86 /* Completeness */ reply
4. 13:20, 23 Mar 2026 (diff | hist) Talk:International nonproprietary name 611 +116 /* Stem table */ reply
5. 12:17, 9 Mar 2026 (diff | hist) Mass spectrometry 5,612 ±0 m add the repeatability figure with the number of injections
6. 17:34, 25 Jan 2026 (diff | hist) Reference standard 5,217 ±0 correct the integration description — valley-to-valley, not drop-line
7. 13:45, 21 Jan 2026 (diff | hist) Talk:Satiety signalling 611 +134 /* Satiation versus satiety */ reply
8. 09:40, 20 Jan 2026 (diff | hist) Talk:Glossary of peptide terminology 400 +164 /* Entries that carry a distinction */ new section
9. 11:30, 19 Jan 2026 (diff | hist) Talk:Dual incretin agonist 674 +119 /* Is "twincretin" acceptable in an encyclopedia? */ new section
10. 09:25, 14 Jan 2026 (diff | hist) Talk:Peptide 400 +213 /* The fifty-residue boundary */ new section
11. 02:06, 18 Dec 2025 (diff | hist) Batch number 4,573 ±0 state that the sample was not drawn blind, so it represents the vial and not the lot
12. 18:57, 2 Dec 2025 (diff | hist) Chinese Peptide Company 15,513 ±0 move a stray full stop inside the reference
13. 16:11, 18 Nov 2025 (diff | hist) Sigma-Aldrich (Shanghai) Trading 16,057 +902 add the standing talk-page note link to the banner
14. 11:24, 5 Nov 2025 (diff | hist) Blind sampling 8,193 ±0 m add the difference between a batch certificate and a lot-specific one
15. 12:32, 30 Sep 2025 (diff | hist) Trial data comparison 6,666 +143 m expand the table so the third syringe scale is covered
16. 05:30, 21 Sep 2025 (diff | hist) Nantong Guangyuan Chemical 14,421 +226 state the city and province of the registered address
17. 04:26, 6 Sep 2025 (diff | hist) GenScript Peptides 3,199 +1,457 add the lead time for catalogue lines, as reported
18. 09:04, 26 Aug 2025 (diff | hist) Insulin syringe 4,944 ±0 add the sharps-disposal cross-link
19. 15:46, 18 Jul 2025 (diff | hist) Hubei Jianxiang Bioscience 7,626 +618 expand §Reception
20. 17:50, 13 May 2025 (diff | hist) Triple agonist 3,428 ±0 fix the amino-acid substitution — position 8, not position 2
21. 11:26, 16 Feb 2025 (diff | hist) SURMOUNT trial programme 3,559 +289 m add the discontinuation rate for adverse events in both arms
22. 09:47, 6 Feb 2025 (diff | hist) USP General Chapter 71 2,935 +681 convert a hard-coded date to the house format
23. 22:19, 24 Jan 2025 (diff | hist) Glossary of peptide terminology 3,581 ±0 m add the year of first description to each glossary term where known
24. 08:30, 22 Jan 2025 (diff | hist) Certificate of analysis 6,396 ±0 add the cost basis, since it shapes who submits
25. 22:20, 4 Jan 2025 (diff | hist) Lot traceability 3,782 +34 m rm the ranking language; this wiki publishes no ranking
26. 13:38, 28 Nov 2024 (diff | hist) Prescribing information 2,473 ±0 alphabetise the see-also list
27. 21:18, 20 Nov 2024 (diff | hist) Enteroendocrine L cell 3,351 ±0 the article treated a rodent finding as human physiology; corrected
28. 21:38, 10 Nov 2024 (diff | hist) Analytical method validation 2,979 ±0 m convert the method-comparison paragraph to a table
29. 21:57, 8 Oct 2024 (diff | hist) Fmoc chemistry 2,683 ±0 m correct the humidity figure — relative humidity needs its temperature
30. 11:48, 25 Sep 2024 (diff | hist) Analytical method validation 2,979 ±0 correct the resolution formula — the denominator is the sum of the widths
31. 15:42, 28 Aug 2024 (diff | hist) Area percent purity 1,321 +1,321 N create article — method stub